Reactive oxygen species produced by altered tumor metabolism impacts cancer stem cell maintenance
Tóm tắt
Từ khóa
Tài liệu tham khảo
Weissman, 2000, Stem cells: units of development, units of regeneration, and units in evolution, Cell, 100, 157, 10.1016/S0092-8674(00)81692-X
Till, 1980, Hemopoietic stem cell differentiation, Biochim. Biophys. Acta, 605, 431
Morrison, 1997, Regulatory mechanisms in stem cell biology, Cell, 88, 287, 10.1016/S0092-8674(00)81867-X
Li, 2010, Coexistence of quiescent and active adult stem cells in mammals, Science, 327, 542, 10.1126/science.1180794
Cheung, 2013, Molecular regulation of stem cell quiescence, Nat. Rev. Mol. Cell Biol., 14, 329, 10.1038/nrm3591
Clevers, 2013, The intestinal crypt, a prototype stem cell compartment, Cell, 154, 274, 10.1016/j.cell.2013.07.004
Clayton, 2007, A single type of progenitor cell maintains normal epidermis, Nature, 446, 185, 10.1038/nature05574
Chakrabarty, 2021, Mitochondria as signaling organelles control mammalian stem cell fate, Cell Stem Cell, 28, 394, 10.1016/j.stem.2021.02.011
Furth, 1937, The transmission of leukemia of mice with a single cell, Am. J. Canc., 31, 276
Kleinsmith, 1964, Multipotentiality of single embryonal carcinoma cells, Canc. Res., 24, 1544
Pierce, 1988, Tumors as caricatures of the process of tissue renewal: prospects for therapy by directing differentiation, Canc. Res., 48, 1996
Libby, 2020, The role of metabolic plasticity in blood and brain stem cell pathophysiology, Canc. Res., 80, 5, 10.1158/0008-5472.CAN-19-1169
Jonasson, 2019, Identification of breast cancer stem cell related genes using functional cellular assays combined with single-cell RNA sequencing in MDA-MB-231 cells, Front. Genet., 10, 500, 10.3389/fgene.2019.00500
Liu, 2018, Comparison of EpCAM(high)CD44(+) cancer stem cells with EpCAM(high)CD44(-) tumor cells in colon cancer by single-cell sequencing, Canc. Biol. Ther., 19, 939, 10.1080/15384047.2018.1456605
Min, 2020, Phenotype-based single cell sequencing identifies diverse genetic subclones in CD133 positive cancer stem cells, Biochem. Biophys. Res. Commun.
Zhao, 2019, Single-cell RNA sequencing reveals the impact of chromosomal instability on glioblastoma cancer stem cells, BMC Med. Genom., 12, 79, 10.1186/s12920-019-0532-5
Suva, 2020, The glioma stem cell model in the era of single-cell genomics, Canc. Cell, 37, 630, 10.1016/j.ccell.2020.04.001
Patel, 2014, Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma, Science, 344, 1396, 10.1126/science.1254257
Tirosh, 2016, Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma, Nature, 539, 309, 10.1038/nature20123
Weng, 2019, Single-cell transcriptomics uncovers glial progenitor diversity and cell fate determinants during development and gliomagenesis, Cell Stem Cell, 24, 707, 10.1016/j.stem.2019.03.006
Panieri, 2016, ROS homeostasis and metabolism: a dangerous liaison in cancer cells, Cell Death Dis., 7, 10.1038/cddis.2016.105
Sies, 2020, Reactive oxygen species (ROS) as pleiotropic physiological signalling agents, Nat. Rev. Mol. Cell Biol., 21, 363, 10.1038/s41580-020-0230-3
Schieber, 2014, ROS function in redox signaling and oxidative stress, Curr. Biol., 24, R453, 10.1016/j.cub.2014.03.034
Finkel, 2011, Signal transduction by reactive oxygen species, J. Cell Biol., 194, 7, 10.1083/jcb.201102095
D'Autreaux, 2007, ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis, Nat. Rev. Mol. Cell Biol., 8, 813, 10.1038/nrm2256
Bedard, 2007, The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology, Physiol. Rev., 87, 245, 10.1152/physrev.00044.2005
Parascandolo, 2019, Carcinogenesis and reactive oxygen species signaling: interaction of the NADPH oxidase NOX1-5 and superoxide dismutase 1-3 signal transduction pathways, Antioxidants Redox Signal., 30, 443, 10.1089/ars.2017.7268
Murphy, 2009, How mitochondria produce reactive oxygen species, Biochem. J., 417, 1, 10.1042/BJ20081386
Muller, 2004, Complex III releases superoxide to both sides of the inner mitochondrial membrane, J. Biol. Chem., 279, 49064, 10.1074/jbc.M407715200
Han, 2001, Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space, Biochem. J., 353, 411, 10.1042/bj3530411
Niedzwiecki, 2019, The exposome: molecules to populations, Annu. Rev. Pharmacol. Toxicol., 59, 107, 10.1146/annurev-pharmtox-010818-021315
Sobotta, 2015, Peroxiredoxin-2 and STAT3 form a redox relay for H2O2 signaling, Nat. Chem. Biol., 11, 64, 10.1038/nchembio.1695
Del Vecchio, 2012, Epidermal growth factor receptor variant III contributes to cancer stem cell phenotypes in invasive breast carcinoma, Canc. Res., 72, 2657, 10.1158/0008-5472.CAN-11-2656
Sette, 2015, Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer, Cell Death Dis., 6, 10.1038/cddis.2015.217
Chang, 2018, Platelet-derived growth factor receptor-alpha and -beta promote cancer stem cell phenotypes in sarcomas, Oncogenesis, 7, 47, 10.1038/s41389-018-0059-1
Kim, 2012, Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity, Genes Dev., 26, 1247, 10.1101/gad.193565.112
Lemmon, 2010, Cell signaling by receptor tyrosine kinases, Cell, 141, 1117, 10.1016/j.cell.2010.06.011
Sundaresan, 1995, Requirement for generation of H2O2 for platelet-derived growth factor signal transduction, Science, 270, 296, 10.1126/science.270.5234.296
Bae, 1997, Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation, J. Biol. Chem., 272, 217, 10.1074/jbc.272.1.217
Denu, 1998, Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation, Biochemistry, 37, 5633, 10.1021/bi973035t
Woo, 2010, Inactivation of peroxiredoxin I by phosphorylation allows localized H(2)O(2) accumulation for cell signaling, Cell, 140, 517, 10.1016/j.cell.2010.01.009
Connor, 2005, Mitochondrial H2O2 regulates the angiogenic phenotype via PTEN oxidation, J. Biol. Chem., 280, 16916, 10.1074/jbc.M410690200
Cantley, 2002, The phosphoinositide 3-kinase pathway, Science, 296, 1655, 10.1126/science.296.5573.1655
Rojo de la Vega, 2018, NRF2 and the hallmarks of cancer, Canc. Cell, 34, 21, 10.1016/j.ccell.2018.03.022
Dodson, 2019, Modulating NRF2 in disease: timing is everything, Annu. Rev. Pharmacol. Toxicol., 59, 555, 10.1146/annurev-pharmtox-010818-021856
Lambeth, 2004, NOX enzymes and the biology of reactive oxygen, Nat. Rev. Immunol., 4, 181, 10.1038/nri1312
DeBerardinis, 2008, The biology of cancer: metabolic reprogramming fuels cell growth and proliferation, Cell Metabol., 7, 11, 10.1016/j.cmet.2007.10.002
Suzuki, 2019, Molecular mechanism of cellular oxidative stress sensing by Keap1, Cell Rep., 28, 746, 10.1016/j.celrep.2019.06.047
Itoh, 1997, An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements, Biochem. Biophys. Res. Commun., 236, 313, 10.1006/bbrc.1997.6943
Yamamoto, 2018, The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis, Physiol. Rev., 98, 1169, 10.1152/physrev.00023.2017
Hayes, 2010, Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway, Antioxidants Redox Signal., 13, 1713, 10.1089/ars.2010.3221
Jung, 2010, The Nrf2 system as a potential target for the development of indirect antioxidants, Molecules, 15, 7266, 10.3390/molecules15107266
Emmink, 2013, The secretome of colon cancer stem cells contains drug-metabolizing enzymes, J. Proteomics, 91, 84, 10.1016/j.jprot.2013.06.027
Jia, 2015, Aberrantly elevated redox sensing factor Nrf2 promotes cancer stem cell survival via enhanced transcriptional regulation of ABCG2 and Bcl-2/Bmi-1 genes, Oncol. Rep., 34, 2296, 10.3892/or.2015.4214
Achuthan, 2011, Drug-induced senescence generates chemoresistant stemlike cells with low reactive oxygen species, J. Biol. Chem., 286, 37813, 10.1074/jbc.M110.200675
Dokic, 2012, Glutathione peroxidase 1 activity dictates the sensitivity of glioblastoma cells to oxidative stress, Glia, 60, 1785, 10.1002/glia.22397
Ishimoto, 2011, CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth, Canc. Cell, 19, 387, 10.1016/j.ccr.2011.01.038
Xue, 2017, The Nrf2/GCH1/BH4 Axis Ameliorates radiation-induced skin injury by modulating the ROS cascade, J. Invest. Dermatol., 137, 2059, 10.1016/j.jid.2017.05.019
Tran, 2018, Reactive species balance via GTP cyclohydrolase I regulates glioblastoma growth and tumor initiating cell maintenance, Neuro Oncol., 20, 1055, 10.1093/neuonc/noy012
Soula, 2020, Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers, Nat. Chem. Biol., 16, 1351, 10.1038/s41589-020-0613-y
Wang, 2019, Nestin regulates cellular redox homeostasis in lung cancer through the Keap1-Nrf2 feedback loop, Nat. Commun., 10, 5043, 10.1038/s41467-019-12925-9
Payandeh, 2020, Role of Nrf2 and mitochondria in cancer stem cells; in carcinogenesis, tumor progression, and chemoresistance, Biochimie, 179, 32, 10.1016/j.biochi.2020.09.014
Chan, 1996, NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development, Proc. Natl. Acad. Sci. U. S. A., 93, 13943, 10.1073/pnas.93.24.13943
Chan, 1999, Nrf2 is essential for protection against acute pulmonary injury in mice, Proc. Natl. Acad. Sci. U. S. A., 96, 12731, 10.1073/pnas.96.22.12731
Ramos-Gomez, 2001, Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice, Proc. Natl. Acad. Sci. U. S. A., 98, 3410, 10.1073/pnas.051618798
Milkovic, 2017, Controversy about pharmacological modulation of Nrf2 for cancer therapy, Redox Biol., 12, 727, 10.1016/j.redox.2017.04.013
Li, 2005, Stem cell niche: structure and function, Annu. Rev. Cell Dev. Biol., 21, 605, 10.1146/annurev.cellbio.21.012704.131525
Jones, 2008, No place like home: anatomy and function of the stem cell niche, Nat. Rev. Mol. Cell Biol., 9, 11, 10.1038/nrm2319
Silvan, 2009, Hypoxia and pluripotency in embryonic and embryonal carcinoma stem cell biology, Differentiation, 78, 159, 10.1016/j.diff.2009.06.002
Kubota, 2008, Bone marrow long label-retaining cells reside in the sinusoidal hypoxic niche, Biochem. Biophys. Res. Commun., 366, 335, 10.1016/j.bbrc.2007.11.086
Parmar, 2007, Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia, Proc. Natl. Acad. Sci. U. S. A., 104, 5431, 10.1073/pnas.0701152104
Panchision, 2009, The role of oxygen in regulating neural stem cells in development and disease, J. Cell. Physiol., 220, 562, 10.1002/jcp.21812
Ejtehadifar, 2015, The effect of hypoxia on mesenchymal stem cell biology, Adv. Pharmaceut. Bull., 5, 141, 10.15171/apb.2015.021
Mohyeldin, 2010, Quinones-Hinojosa A: oxygen in stem cell biology: a critical component of the stem cell niche, Cell Stem Cell, 7, 150, 10.1016/j.stem.2010.07.007
Morriss, 1979, Effect of oxygen concentration on morphogenesis of cranial neural folds and neural crest in cultured rat embryos, J. Embryol. Exp. Morphol., 54, 17
Busuttil, 2003, Oxygen accelerates the accumulation of mutations during the senescence and immortalization of murine cells in culture, Aging Cell, 2, 287, 10.1046/j.1474-9728.2003.00066.x
Ito, 2006, Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells, Nat. Med., 12, 446, 10.1038/nm1388
Chen, 2007, Oxygen tension regulates survival and fate of mouse central nervous system precursors at multiple levels, Stem Cell., 25, 2291, 10.1634/stemcells.2006-0609
Pistollato, 2007, Oxygen tension controls the expansion of human CNS precursors and the generation of astrocytes and oligodendrocytes, Mol. Cell. Neurosci., 35, 424, 10.1016/j.mcn.2007.04.003
Gustafsson, 2005, Hypoxia requires notch signaling to maintain the undifferentiated cell state, Dev. Cell, 9, 617, 10.1016/j.devcel.2005.09.010
Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024
Yoshida, 2009, Hypoxia enhances the generation of induced pluripotent stem cells, Cell Stem Cell, 5, 237, 10.1016/j.stem.2009.08.001
Mathieu, 2013, Hypoxia induces re-entry of committed cells into pluripotency, Stem Cell., 31, 1737, 10.1002/stem.1446
Yang, 2020, Targeting cancer stem cell pathways for cancer therapy, Signal Transduct. Target Ther., 5, 8, 10.1038/s41392-020-0110-5
Wang, 1995, Purification and characterization of hypoxia-inducible factor 1, J. Biol. Chem., 270, 1230, 10.1074/jbc.270.3.1230
Wang, 1995, Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension, Proc. Natl. Acad. Sci. U. S. A., 92, 5510, 10.1073/pnas.92.12.5510
Acker, 2004, Hypoxia and hypoxia inducible factors (HIF) as important regulators of tumor physiology, Canc. Treat Res., 117, 219, 10.1007/978-1-4419-8871-3_14
Lee, 2020, Cellular adaptation to hypoxia through hypoxia inducible factors and beyond, Nat. Rev. Mol. Cell Biol., 21, 268, 10.1038/s41580-020-0227-y
Wenger, 2005, Integration of oxygen signaling at the consensus HRE, Sci. STKE, 2005, re12, 10.1126/stke.3062005re12
Pawlus, 2013, STAT3 or USF2 contributes to HIF target gene specificity, PloS One, 8, 10.1371/journal.pone.0072358
Keith, 2011, HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression, Nat. Rev. Canc., 12, 9, 10.1038/nrc3183
Mathieu, 2014, Hypoxia-inducible factors have distinct and stage-specific roles during reprogramming of human cells to pluripotency, Cell Stem Cell, 14, 592, 10.1016/j.stem.2014.02.012
Covello, 2006, HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth, Genes Dev., 20, 557, 10.1101/gad.1399906
Carnero, 2016, The hypoxic microenvironment: a determinant of cancer stem cell evolution, Bioessays, 38, S65
Qian, 2019, Hypoxia-induced phenotypes that mediate tumor heterogeneity, Adv. Exp. Med. Biol., 1136, 43, 10.1007/978-3-030-12734-3_3
Li, 2009, Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells, Canc. Cell, 15, 501, 10.1016/j.ccr.2009.03.018
Vadde, 2017, Role of hypoxia-inducible factors (HIF) in the maintenance of stemness and malignancy of colorectal cancer, Crit. Rev. Oncol. Hematol., 113, 22, 10.1016/j.critrevonc.2017.02.025
Soeda, 2009, Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha, Oncogene, 28, 3949, 10.1038/onc.2009.252
Heddleston, 2009, The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype, Cell Cycle, 8, 3274, 10.4161/cc.8.20.9701
Heddleston, 2010, Hypoxia inducible factors in cancer stem cells, Br. J. Canc., 102, 789, 10.1038/sj.bjc.6605551
Das, 2019, MYC regulates the HIF2alpha stemness pathway via Nanog and Sox2 to maintain self-renewal in cancer stem cells versus non-stem cancer cells, Canc. Res., 79, 4015, 10.1158/0008-5472.CAN-18-2847
Franovic, 2009, Human cancers converge at the HIF-2alpha oncogenic axis, Proc. Natl. Acad. Sci. U. S. A., 106, 21306, 10.1073/pnas.0906432106
Kim, 2013, High aldehyde dehydrogenase activity enhances stem cell features in breast cancer cells by activating hypoxia-inducible factor-2alpha, Canc. Lett., 333, 18, 10.1016/j.canlet.2012.11.026
Semenza, 2017, Hypoxia-inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype, EMBO J., 36, 252, 10.15252/embj.201695204
Narayanan, 2020, Targeting the redox landscape in cancer therapy, Cancers, 12, 10.3390/cancers12071706
Guzy, 2005, Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing, Cell Metabol., 1, 401, 10.1016/j.cmet.2005.05.001
Schonfeld, 2011, Non-esterified polyunsaturated fatty acids distinctly modulate the mitochondrial and cellular ROS production in normoxia and hypoxia, J. Neurochem., 118, 69, 10.1111/j.1471-4159.2011.07286.x
Chandel, 2000, Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing, J. Biol. Chem., 275, 25130, 10.1074/jbc.M001914200
Bell, 2007, The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production, J. Cell Biol., 177, 1029, 10.1083/jcb.200609074
Brunelle, 2005, Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation, Cell Metabol., 1, 409, 10.1016/j.cmet.2005.05.002
Horak, 2010, Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis, Proc. Natl. Acad. Sci. U. S. A., 107, 4675, 10.1073/pnas.0907705107
Lu, 2015, Chemotherapy triggers HIF-1-dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype, Proc. Natl. Acad. Sci. U. S. A., 112, E4600, 10.1073/pnas.1513433112
Stockwell, 2017, Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease, Cell, 171, 273, 10.1016/j.cell.2017.09.021
Duarte, 2020, NRF2 and hypoxia-inducible factors: key players in the redox control of systemic iron homeostasis, Antioxidants Redox Signal.
Wang, 2021, Frizzled-7 identifies platinum-tolerant ovarian cancer cells susceptible to ferroptosis, Canc. Res., 81, 384, 10.1158/0008-5472.CAN-20-1488
Sun, 2021, Dichloroacetate attenuates the stemness of colorectal cancer cells via triggering ferroptosis through sequestering iron in lysosomes, Environ. Toxicol., 36, 520, 10.1002/tox.23057
Taylor, 2019, Small-molecule ferroptotic agents with potential to selectively target cancer stem cells, Sci. Rep., 9, 5926, 10.1038/s41598-019-42251-5
Chen, 2020, A promising new anti-cancer strategy: iron chelators targeting CSCs, Acta Med. Okayama, 74, 1
Fiorillo, 2020, Deferiprone (DFP) targets cancer stem cell (CSC) propagation by inhibiting mitochondrial metabolism and inducing ROS production, Cells, 9, 10.3390/cells9061529
Basuli, 2017, Iron addiction: a novel therapeutic target in ovarian cancer, Oncogene, 36, 4089, 10.1038/onc.2017.11
Recalcati, 2019, Dysregulation of iron metabolism in cancer stem cells, Free Radic. Biol. Med., 133, 216, 10.1016/j.freeradbiomed.2018.07.015
Schonberg, 2015, Preferential iron trafficking characterizes glioblastoma stem-like cells, Canc. Cell, 28, 441, 10.1016/j.ccell.2015.09.002
Lobello, 2016, Ferritin heavy chain is a negative regulator of ovarian cancer stem cell expansion and epithelial to mesenchymal transition, Oncotarget, 7, 62019, 10.18632/oncotarget.11495
Chen, 2015, The Warburg effect: evolving interpretations of an established concept, Free Radic. Biol. Med., 79, 253, 10.1016/j.freeradbiomed.2014.08.027
Luo, 2019, Targeting cancer stem cell redox metabolism to enhance therapy responses, Semin. Radiat. Oncol., 29, 42, 10.1016/j.semradonc.2018.10.003
Folmes, 2011, Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming, Cell Metabol., 14, 264, 10.1016/j.cmet.2011.06.011
Panopoulos, 2012, The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming, Cell Res., 22, 168, 10.1038/cr.2011.177
Zhang, 2012, Metabolic regulation in pluripotent stem cells during reprogramming and self-renewal, Cell Stem Cell, 11, 589, 10.1016/j.stem.2012.10.005
Nadzialek, 2010, Understanding the gap between the estrogenicity of an effluent and its real impact into the wild, Sci. Total Environ., 408, 812, 10.1016/j.scitotenv.2009.09.002
Pfeiffer, 2001, Cooperation and competition in the evolution of ATP-producing pathways, Science, 292, 504, 10.1126/science.1058079
Kim, 2016, ROS homeostasis and metabolism: a critical liaison for cancer therapy, Exp. Mol. Med., 48, e269, 10.1038/emm.2016.119
Xie, 2014, Targeting lactate dehydrogenase--a inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells, Cell Metabol., 19, 795, 10.1016/j.cmet.2014.03.003
Ji, 2020, A ketogenic diet attenuates proliferation and stemness of glioma stemlike cells by altering metabolism resulting in increased ROS production, Int. J. Oncol., 56, 606
Milder, 2012, Modulation of oxidative stress and mitochondrial function by the ketogenic diet, Epilepsy Res., 100, 295, 10.1016/j.eplepsyres.2011.09.021
Zhou, 2011, Metabolic alterations in highly tumorigenic glioblastoma cells: preference for hypoxia and high dependency on glycolysis, J. Biol. Chem., 286, 32843, 10.1074/jbc.M111.260935
Flavahan, 2013, Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake, Nat. Neurosci., 16, 1373, 10.1038/nn.3510
Ciavardelli, 2014, Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment, Cell Death Dis., 5, e1336, 10.1038/cddis.2014.285
Liao, 2014, Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism, PloS One, 9, 10.1371/journal.pone.0084941
Dong, 2020, Regulation of cancer cell metabolism: oncogenic MYC in the driver's seat, Signal Transduct. Target Ther., 5, 124, 10.1038/s41392-020-00235-2
Kim, 2004, Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays, Mol. Cell Biol., 24, 5923, 10.1128/MCB.24.13.5923-5936.2004
Osthus, 2000, Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc, J. Biol. Chem., 275, 21797, 10.1074/jbc.C000023200
David, 2010, HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer, Nature, 463, 364, 10.1038/nature08697
Anastasiou, 2011, Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses, Science, 334, 1278, 10.1126/science.1211485
Zoller, 2011, CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?, Nat. Rev. Canc., 11, 254, 10.1038/nrc3023
Tamada, 2012, Modulation of glucose metabolism by CD44 contributes to antioxidant status and drug resistance in cancer cells, Canc. Res., 72, 1438, 10.1158/0008-5472.CAN-11-3024
Nam, 2016, Ablation of CD44 induces glycolysis-to-oxidative phosphorylation transition via modulation of the c-Src-Akt-LKB1-AMPKalpha pathway, Biochem. J., 473, 3013, 10.1042/BCJ20160613
Luo, 2018, Targeting breast cancer stem cell state equilibrium through modulation of redox signaling, Cell Metabol., 28, 69, 10.1016/j.cmet.2018.06.006
Dixon, 2014, Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis, Elife, 3, 10.7554/eLife.02523
Toyokuni, 2017, Iron and thiol redox signaling in cancer: an exquisite balance to escape ferroptosis, Free Radic. Biol. Med., 108, 610, 10.1016/j.freeradbiomed.2017.04.024
Xu, 2020, Targeting SLC7A11 specifically suppresses the progression of colorectal cancer stem cells via inducing ferroptosis, Eur. J. Pharmaceut. Sci., 152, 105450, 10.1016/j.ejps.2020.105450
Janiszewska, 2012, Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells, Genes Dev., 26, 1926, 10.1101/gad.188292.112
Lee, 2017, MYC and MCL1 cooperatively promote chemotherapy-resistant breast cancer stem cells via regulation of mitochondrial oxidative phosphorylation, Cell Metabol., 26, 633, 10.1016/j.cmet.2017.09.009
Sancho, 2015, MYC/PGC-1alpha balance determines the metabolic phenotype and plasticity of pancreatic cancer stem cells, Cell Metabol., 22, 590, 10.1016/j.cmet.2015.08.015
Ambrosini, 2020, Progressively de-differentiated pancreatic cancer cells shift from glycolysis to oxidative metabolism and gain a quiescent stem state, Cells, 9, 10.3390/cells9071572
Chen, 2016, NANOG metabolically reprograms tumor-initiating stem-like cells through tumorigenic changes in oxidative phosphorylation and fatty acid metabolism, Cell Metabol., 23, 206, 10.1016/j.cmet.2015.12.004
Ye, 2016, Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche, Cell Stem Cell, 19, 23, 10.1016/j.stem.2016.06.001
Jaswal, 2011, Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart, Biochim. Biophys. Acta, 1813, 1333, 10.1016/j.bbamcr.2011.01.015
Lagadinou, 2013, BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells, Cell Stem Cell, 12, 329, 10.1016/j.stem.2012.12.013
Vlashi, 2011, Metabolic state of glioma stem cells and nontumorigenic cells, Proc. Natl. Acad. Sci. U. S. A., 108, 16062, 10.1073/pnas.1106704108
Makena, 2020, Cancer stem cells: road to therapeutic resistance and strategies to overcome resistance, Biochim. Biophys. Acta (BBA) - Mol. Basis Dis., 1866, 165339, 10.1016/j.bbadis.2018.11.015
Chabner, 2005, Timeline: chemotherapy and the war on cancer, Nat. Rev. Canc., 5, 65, 10.1038/nrc1529
Baskar, 2012, Cancer and radiation therapy: current advances and future directions, Int. J. Med. Sci., 9, 193, 10.7150/ijms.3635
Roos, 2016, DNA damage and the balance between survival and death in cancer biology, Nat. Rev. Canc., 16, 20, 10.1038/nrc.2015.2
Conklin, 2004, Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness, Integr. Canc. Ther., 3, 294, 10.1177/1534735404270335
Jackson, 2009, The DNA-damage response: new molecular insights and new approaches to cancer therapy, Biochem. Soc. Trans., 37, 483, 10.1042/BST0370483
Nassar, 2016, Cancer stem cells: basic concepts and therapeutic implications, Annu. Rev. Pathol., 11, 47, 10.1146/annurev-pathol-012615-044438
Diehn, 2009, Association of reactive oxygen species levels and radioresistance in cancer stem cells, Nature, 458, 780, 10.1038/nature07733
Bao, 2006, Glioma stem cells promote radioresistance by preferential activation of the DNA damage response, Nature, 444, 756, 10.1038/nature05236
Desai, 2014, CD133+ cells contribute to radioresistance via altered regulation of DNA repair genes in human lung cancer cells, Radiother. Oncol., 110, 538, 10.1016/j.radonc.2013.10.040
Lagadec, 2012, Radiation-induced reprogramming of breast cancer cells, Stem Cell., 30, 833, 10.1002/stem.1058
Vassalli, 2019, Aldehyde dehydrogenases: not just markers, but functional regulators of stem cells, Stem Cell. Int., 2019, 3904645
Ginestier, 2007, ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome, Cell Stem Cell, 1, 555, 10.1016/j.stem.2007.08.014
Li, 2010, ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome, Lab. Invest., 90, 234, 10.1038/labinvest.2009.127
van den Hoogen, 2010, High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer, Canc. Res., 70, 5163, 10.1158/0008-5472.CAN-09-3806
Sullivan, 2010, Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling, Canc. Res., 70, 9937, 10.1158/0008-5472.CAN-10-0881
Rasper, 2010, Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity, Neuro Oncol., 12, 1024, 10.1093/neuonc/noq070
Altman, 2016, From Krebs to clinic: glutamine metabolism to cancer therapy, Nat. Rev. Canc., 16, 749, 10.1038/nrc.2016.114
Mitsuishi, 2012, Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming, Canc. Cell, 22, 66, 10.1016/j.ccr.2012.05.016
Han, 2020, IDH mutation in glioma: molecular mechanisms and potential therapeutic targets, Br. J. Canc., 122, 1580, 10.1038/s41416-020-0814-x
Liu, 2019, Targeting IDH1-mutated malignancies with NRF2 blockade, J. Natl. Cancer Inst., 111, 1033, 10.1093/jnci/djy230
Shi, 2015, Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation, Tumour Biol., 36, 655, 10.1007/s13277-014-2644-z
Gilbert, 2014, Autophagy and oxidative stress in gliomas with IDH1 mutations, Acta Neuropathol., 127, 221, 10.1007/s00401-013-1194-6
Mohrenz, 2013, Isocitrate dehydrogenase 1 mutant R132H sensitizes glioma cells to BCNU-induced oxidative stress and cell death, Apoptosis, 18, 1416, 10.1007/s10495-013-0877-8
McBrayer, 2018, Transaminase inhibition by 2-hydroxyglutarate impairs glutamate biosynthesis and redox homeostasis in glioma, Cell, 175, 101, 10.1016/j.cell.2018.08.038
Bensimon, 2016, Forced extinction of CD24 stem-like breast cancer marker alone promotes radiation resistance through the control of oxidative stress, Mol. Carcinog., 55, 245, 10.1002/mc.22273
Chang, 2014, Distinct subpopulations of head and neck cancer cells with different levels of intracellular reactive oxygen species exhibit diverse stemness, proliferation, and chemosensitivity, Canc. Res., 74, 6291, 10.1158/0008-5472.CAN-14-0626
Harris, 2015, Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression, Canc. Cell, 27, 211, 10.1016/j.ccell.2014.11.019
Yoshimoto, 2012, Complex DNA repair pathways as possible therapeutic targets to overcome temozolomide resistance in glioblastoma, Front. Oncol., 2, 186, 10.3389/fonc.2012.00186
Esteller, 2000, Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents, N. Engl. J. Med., 343, 1350, 10.1056/NEJM200011093431901
Hegi, 2005, MGMT gene silencing and benefit from temozolomide in glioblastoma, N. Engl. J. Med., 352, 997, 10.1056/NEJMoa043331
Venere, 2014, Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells, Cell Death Differ., 21, 258, 10.1038/cdd.2013.136
Ning, 2019, Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastoma, Nat. Commun., 10, 2910, 10.1038/s41467-019-10993-5
Rasmussen, 2016, BRCA1-regulated RRM2 expression protects glioblastoma cells from endogenous replication stress and promotes tumorigenicity, Nat. Commun., 7, 13398, 10.1038/ncomms13398
van Velthoven, 2019, Stem cell quiescence: dynamism, restraint, and cellular idling, Cell Stem Cell, 24, 213, 10.1016/j.stem.2019.01.001
Bonnet, 1997, Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell, Nat. Med., 3, 730, 10.1038/nm0797-730
Deleyrolle, 2011, Evidence for label-retaining tumour-initiating cells in human glioblastoma, Brain, 134, 1331, 10.1093/brain/awr081
Dembinski, 2009, Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma, Clin. Exp. Metastasis, 26, 611, 10.1007/s10585-009-9260-0
Yumoto, 2014, A novel method for monitoring tumor proliferation in vivo using fluorescent dye DiD, Cytometry, 85, 548, 10.1002/cyto.a.22434
Kusumbe, 2009, Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy, Canc. Res., 69, 9245, 10.1158/0008-5472.CAN-09-2802
Moore, 2012, Slow-cycling therapy-resistant cancer cells, Stem Cell. Dev., 21, 1822, 10.1089/scd.2011.0477
Hoang-Minh, 2018, Infiltrative and drug-resistant slow-cycling cells support metabolic heterogeneity in glioblastoma, EMBO J., 37, 10.15252/embj.201798772
Chen, 2012, A restricted cell population propagates glioblastoma growth after chemotherapy, Nature, 488, 522, 10.1038/nature11287
Sharanek, 2020, OSMR controls glioma stem cell respiration and confers resistance of glioblastoma to ionizing radiation, Nat. Commun., 11, 4116, 10.1038/s41467-020-17885-z
Shiokawa, 2020, Slow-cycling cancer stem cells regulate progression and chemoresistance in colon cancer, Canc. Res., 80, 4451, 10.1158/0008-5472.CAN-20-0378
Peng, 2020, Identification of a subpopulation of long-term tumor-initiating cells in colon cancer, Biosci. Rep., 40, 10.1042/BSR20200437
Tabassum, 2015, Oxaliplatin-induced oxidative stress provokes toxicity in isolated rat liver mitochondria, Arch. Med. Res., 46, 597, 10.1016/j.arcmed.2015.10.002
Fu, 2014, Antioxidants decrease the apoptotic effect of 5-Fu in colon cancer by regulating Src-dependent caspase-7 phosphorylation, Cell Death Dis., 5, e983, 10.1038/cddis.2013.509
Kops, 2002, Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress, Nature, 419, 316, 10.1038/nature01036
Haraguchi, 2010, CD13 is a therapeutic target in human liver cancer stem cells, J. Clin. Invest., 120, 3326, 10.1172/JCI42550
Patterson, 2019, ROS and oxidative stress are elevated in mitosis during asynchronous cell cycle progression and are exacerbated by mitotic arrest, Cell Syst., 8, 163, 10.1016/j.cels.2019.01.005
Rey, 2010, Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling, Cardiovasc. Res., 86, 236, 10.1093/cvr/cvq045
Lugano, 2020, Tumor angiogenesis: causes, consequences, challenges and opportunities, Cell. Mol. Life Sci., 77, 1745, 10.1007/s00018-019-03351-7